China Hepatitis B Vaccine Makers Halt Output

China Hepatitis B Vaccine Makers Halt Output Play

Jan. 3 (Bloomberg) -- Three Chinese drug producers that make about 80 percent of the nation’s hepatitis B vaccines halted output because they don’t meet new production-quality requirements, Xinhua News Agency said on its microblog. Stephen Engle has more on Bloomberg Television's "First Up." (Source: Bloomberg)

  • On Air Now

    Street Smart with Trish Regan Watch Now

  • Next

    Taking Stock with Pimm Fox

blog comments powered by Disqus